| WA group | NWA group | p - value |
---|---|---|---|
All participants (n = 130) | 97 | 33 |  |
Age ± SD (years) | 69.3 ± 10.1 | 79.0 ± 7.9 | <  0.0001 |
Sex (male / female) | 64 / 33 | 22 / 11 | >  0.9999 |
Hospital stay length (days) | 41.9 ± 45.0 | 66.3 ± 65.4 | 0.0188 |
Stroke type | |||
 HS with ventricular perforation | 4 (4.1) | 6 (18.2) | reference§ |
 HS without ventricular perforation | 20 (20.6) | 5 (15.2) | 0.0560 |
 IS, lacunar | 21 (21.6) | 5 (15.2) | 0.0483 |
 IS, non-lacunar | 52 (53.6) | 17 (51.5) | 0.0533 |
 Stroke size (mm) | 21.4 ± 17.9 | 21.3 ± 15.7 | 0.9759 |
Comorbidities | |||
 CVD history | 19 (19.6) | 18 (54.5) | 0.0003 |
 Dementia | 9 (9.3) | 14 (42.4) | <  0.0001 |
 DM | 30 (30.9) | 14 (42.4) | 0.3209 |
 HT | 70 (72.2) | 26 (78.8) | 0.6041 |
 HLP | 26 (26.8) | 7 (21.2) | 0.6847 |
 Smoking | 47 (48.5) | 10 (30.3) | 0.1070 |
 Cardiac disease | 30 (30.9) | 17 (51.5) | 0.0553 |
 Malignancy * | 8 (8.2) | 5 (15.2) | 0.4202 |
CI | Â | Â | 0.1016 |
 Mode | 2 | 3 |  |
 Median | 2 | 3 |  |
 Maximal daily activity (METs) |  |  | 0.0046 |
 Mode | 8 | 8 |  |
 Median | 8 | 5 |  |